Ikarian Capital, LLC Adverum Biotechnologies, Inc. Put Options Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 17, 2021	SELL	$9.26 - $14.36 $414,848 - $643,328	-44,800 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$9.84 - $14.26 $2.46 Million - $3.57 Million	-250,000 Reduced 84.8%	44,800 $486,000
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $2.06 Million - $4.33 Million	200,000 Added 210.97%	294,800 $3.04 Million
Q2 2020 Aug 14, 2020	BUY	$8.53 - $25.64 $808,643 - $2.43 Million	94,800 New	94,800 $1.98 Million

2.53M

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $689M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.